Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Efinopegdutide (JNJ-64565111) is a potent dual agonist for the glucagon-like peptide-1 (GLP-1) and glucagon receptors (GluR), showing efficacy in activating both receptors. It has potential applications in the research of nonalcoholic steatohepatitis (NASH) [1].
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
5 mg | Inquiry | Inquiry | |
50 mg | Inquiry | Inquiry |
Description | Efinopegdutide (JNJ-64565111) is a potent dual agonist for the glucagon-like peptide-1 (GLP-1) and glucagon receptors (GluR), showing efficacy in activating both receptors. It has potential applications in the research of nonalcoholic steatohepatitis (NASH) [1]. |
Molecular Weight | N/A |
CAS No. | 2055640-93-0 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Efinopegdutide 2055640-93-0 inhibitor inhibit